BIOMAT Database Logo BIOMAT Database Logo

Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease. 2008

Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Department of Hematology, Meitetsu Hospital, 2-26-11 Sakoh, Nishi-ku, Nagoya, 451-8511, Japan. akunitom@mx5.suisui-w.ne.jp.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
[Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease].
March 2008, Annales de dermatologie et de venereologie,
Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Successful treatment of sclerotic cutaneous graft-versus-host disease using extracorporeal photopheresis.
January 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
September 2003, Transplant international : official journal of the European Society for Organ Transplantation,
Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Chronic cutaneous graft-versus-host disease: successful treatment with UVB.
November 1991, The British journal of dermatology,
Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506).
May 2002, Cornea,
Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease.
June 2010, Pharmacy world & science : PWS,
Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease.
March 2015, American journal of ophthalmology,
Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Successful treatment of chronic cutaneous graft-versus-host-disease (GVHD) with penicillamine.
January 1983, Clinical and laboratory haematology,
Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.
August 2012, Korean journal of ophthalmology : KJO,
Akane Kunitomi, and Hiroatsu Iida, and Yoshikazu Kamiya, and Mayuko Hayashi, and Hiroshi Sao
Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
May 2007, Pediatric transplantation,
Copied contents to your clipboard!